Literature DB >> 24065529

Different anti-apoptotic effects of normal and asthmatic serum on normal eosinophil apoptosis depending on house dust mite-specific IgE.

In Sik Kim1, Mi Jin Kim, Do Hyung Kim, Eugene Choi, Ji-Sook Lee.   

Abstract

We investigated the effect of asthmatic serum on constitutive eosinophil apoptosis in normal subjects. Eosinophil apoptosis in normal subjects was inhibited by asthmatic serum but not normal serum. In a detailed analysis based on the presence of house dust mite (HDM) IgE, HDM IgE-positive (+) asthmatic serum was more effective for eosinophil apoptosis than that of HDM IgE-negative (-) asthmatic serum. HDM IgE+ asthmatic serum inhibited both HDM IgE- and HDM IgE+ normal eosinophil apoptosis, and HDM IgE- asthmatic serum suppressed eosinophil apoptosis of HDM IgE+ normal. HDM IgE- normal serum did not inhibit either HDM IgE- or HDM IgE+ normal eosinophil apoptosis, and HDM IgE+ normal serum inhibited HDM IgE+ normal eosinophil apoptosis. The kind of HDM IgE (Dermatophagoides pteronissinus-specific IgE and Dermatophagoides farinae-specific IgE) was not related to the effect of asthmatic serum on eosinophil apoptosis. Extracts of DP and DF, Der p1, and Der p2, were not effective for eosinophil apoptosis. HDM IgE+ asthmatic serum inhibited cleavage of procaspase 9 and procaspase 3. Asthmatic serum induced Akt and ERK phosphorylation, and ERK activation was suppressed by AKTi. Taken together, asthmatic serum inhibited normal eosinophil apoptosis via PI3K/Akt/ERK cascade. The novel approach taken in this study provided better insight into HDM-associated anti-apoptotic mechanism of eosinophils in patients with asthma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065529     DOI: 10.1007/s11033-013-2695-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

Review 1.  Asthma from a pharmacogenomic point of view.

Authors:  C Szalai; I Ungvári; L Pelyhe; G Tölgyesi; A Falus
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

Review 2.  Pathogenesis of asthma.

Authors:  Stephen T Holgate
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

Review 3.  Targeting eosinophil biology in asthma therapy.

Authors:  Michael Wegmann
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-07       Impact factor: 6.914

4.  Differential effect of CCL2 on constitutive neutrophil apoptosis between normal and asthmatic subjects.

Authors:  Eun Ju Yang; Eugene Choi; Jesang Ko; Dong-Hee Kim; Ji-Sook Lee; In Sik Kim
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

5.  Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects.

Authors:  Polina Stepensky; Baerbel Keller; Mary Buchta; Anne-Kathrin Kienzler; Orly Elpeleg; Raz Somech; Sivan Cohen; Idit Shachar; Lisa A Miosge; Michael Schlesier; Ilka Fuchs; Anselm Enders; Hermann Eibel; Bodo Grimbacher; Klaus Warnatz
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

Review 6.  The role of indoor allergens in the development of asthma.

Authors:  Jonathan M Gaffin; Wanda Phipatanakul
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-04

7.  Association of pediatric asthma severity with exposure to common household dust allergens.

Authors:  Janneane F Gent; Kathleen Belanger; Elizabeth W Triche; Michael B Bracken; William S Beckett; Brian P Leaderer
Journal:  Environ Res       Date:  2009-05-26       Impact factor: 6.498

Review 8.  Granulocyte apoptosis in the pathogenesis and resolution of lung disease.

Authors:  Stephen M Bianchi; David H Dockrell; Stephen A Renshaw; Ian Sabroe; Moira K B Whyte
Journal:  Clin Sci (Lond)       Date:  2006-03       Impact factor: 6.124

9.  Association of house dust mite-specific IgE with asthma control, medications and household pets.

Authors:  Pia Marie Albano; John Donnie A Ramos
Journal:  Asia Pac Allergy       Date:  2011-10-11

Review 10.  Role of IL-10 in the resolution of airway inflammation.

Authors:  Yoshiko Ogawa; Enrico A Duru; Bill T Ameredes
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.616

View more
  4 in total

Review 1.  Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: Where do we stand today?

Authors:  Jakub Novosad; Irena Krčmová
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

Review 2.  Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.

Authors:  Corrado Pelaia; Cecilia Calabrese; Rosa Terracciano; Francesco de Blasio; Alessandro Vatrella; Girolamo Pelaia
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

3.  Regulation of constitutive neutrophil apoptosis due to house dust mite allergen in normal and allergic rhinitis subjects.

Authors:  Eun Hye Kim; Ji-Sook Lee; Na Rae Lee; Seung Yeop Baek; Eun Jeong Kim; Soo Jin Lee; In Sik Kim
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

4.  Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma.

Authors:  Nicola Lombardo; Corrado Pelaia; Marco Ciriolo; Marcello Della Corte; Giovanna Piazzetta; Nadia Lobello; Pasquale Viola; Girolamo Pelaia
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.